Trial record 1 of 1 for:    NCT01416038
Previous Study | Return to List | Next Study

Phase 1-2 Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
ImmunoVaccine Technologies, Inc.
ClinicalTrials.gov Identifier:
NCT01416038
First received: August 9, 2011
Last updated: January 16, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: April 2013 (Final data collection date for primary outcome measure)